Eli Lilly has filed six lawsuits, including five in Texas, against companies it says are illegally selling unapproved versions of its experimental weight-loss drug retatrutide amid growing concern over a global black market for counterfeit and compounded obesity treatments.
Eli Lilly has filed six lawsuits, including five in Texas, against companies it says are illegally selling unapproved versions of its experimental weight-loss drug retatrutide amid growing concern over a global black market for counterfeit and compounded obesity treatments.
